Items without sitelinks
Showing below up to 50 results in range #1,161 to #1,210.
- hormone metabolic process (Q21343)
- peptide hormone processing (Q21342)
- glucagon processing (Q21341)
- Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) (Q21340)
- protein precursor (Q21339)
- proglucagon (Q21338)
- protein fragment (Q21337)
- healthy weight (Q21334)
- disability affecting intellectual abilities (Q21332)
- dementia (Q21331)
- misplacing things and losing the ability to retrace steps (Q21330)
- changes in mood and personality (Q21329)
- problems with words in speaking or writing (Q21328)
- withdrawal from work or social activities (Q21327)
- decreased or poor judgment (Q21326)
- trouble understanding visual images and spatial relationships (Q21325)
- difficulty completing familiar tasks at home, at work or at leisure (Q21324)
- challenges in planning or solving problems (Q21323)
- confusion with time and space (Q21322)
- memory loss that disrupts daily life (Q21321)
- annum (Q21320)
- lists of centenarians (Q21319)
- centenarian (Q21318)
- supercentenarian (Q21317)
- oldest human (Q21316)
- longevity (Q21315)
- list of the verified oldest people (Q21314)
- old age (Q21313)
- elderly people (Q21312)
- aging-associated disease (Q21311)
- structural motif (Q21310)
- Microtubule associated protein, tubulin-binding repeat (Q21309)
- Microtubule associated protein, tubulin-binding repeat, protein family (Q21308)
- cytoskeletal proteins (Q21307)
- microtubule-associated proteins (Q21306)
- Microtubule-associated protein Tau (Q21305)
- microtubule associated protein tau (Q21304)
- inclusion body (Q21303)
- neurofibrillary tangle (Q21302)
- tauopathy (Q21301)
- Alzheimer's disease (Q21300)
- weight loss product (Q21297)
- pathological conditions, signs and symptoms (Q21295)
- anatomical pathological condition (Q21294)
- etiopathogenesis (Q21292)
- atherogenesis (Q21291)
- arteriosclerotic cardiovascular disease (Q21290)
- morbidity (Q21287)
- immortality (Q21285)
- cell culture (Q21284)